Nila et al. (2022), in a systematic review and meta-analysis of 80 PD patients and 80 controls, suggested that exosomal biomarkers, including α-synuclein, could serve as potential non-invasive diagnostic tools for PD. This evidence concerns the gene SNCA and Parkinson disease.